Introduction
Multiple myeloma is a type of blood cancer that develops from plasma cells, a type of white blood cell found in the bone marrow. Plasma cells normally help the body fight infections by producing antibodies. In multiple myeloma, abnormal plasma cells multiply uncontrollably, interfering with normal blood cell production and damaging bones, kidneys, and immune function.
Myeloma can cause symptoms such as bone pain, anemia-related fatigue, frequent infections, and kidney problems. In some cases, it is detected early through abnormal blood tests before symptoms become severe.
Effective myeloma care requires accurate diagnosis, disease staging, and personalized treatment planning, often involving a combination of medications, supportive therapies, and in selected cases stem cell transplantation.
Türkiye is a trusted destination for advanced hematology-oncology care, offering experienced specialists, modern diagnostic laboratories, and access to contemporary myeloma therapies.
Averia Health supports international patients through ethical, structured, and fully coordinated multiple myeloma care focused on safety, transparency, and long-term treatment continuity.
Why Choose Türkiye for Multiple Myeloma Treatment
Türkiye is internationally recognized for high-quality hematology-oncology services because of:
- Experienced hematology-oncology specialists
- Advanced bone marrow diagnostic services
- Modern imaging for bone disease evaluation
- Access to targeted therapies and immunotherapy-based regimens
- Stem cell transplant coordination in specialized centers (selected cases)
- Internationally accredited hospitals
Türkiye combines clinical expertise with comprehensive cancer care.
Why Choose Averia Health
Averia Health provides comprehensive coordination for multiple myeloma diagnosis and treatment:
- Pre-arrival review of blood tests, imaging, and prior treatment history
- Referral to experienced myeloma specialists
- Coordination of advanced diagnostic confirmation and staging
- Clear explanation of disease status and treatment options
- Personalized treatment planning with supportive care coordination
- Interpreter services for full clarity
- 24/7 patient support during your stay
- Post-treatment follow-up and international care coordination
Our approach prioritizes ethical care, clinical accuracy, and patient reassurance.
What Is Multiple Myeloma?
Multiple myeloma involves abnormal plasma cells producing monoclonal proteins (M-protein) that can be detected in blood or urine. These cells can:
- Weaken bones and increase fracture risk
- Reduce normal blood cell production (anemia, low immunity, bleeding risk)
- Damage kidneys
- Increase calcium levels in the blood
Myeloma is often described along a spectrum, including:
- MGUS (monoclonal gammopathy of undetermined significance)
- Smoldering myeloma
- Active multiple myeloma requiring treatment
Accurate classification is essential.
Symptoms of Multiple Myeloma
Symptoms may include:
- Bone pain (especially back, ribs, hips)
- Fatigue and weakness (anemia)
- Frequent infections
- Unexplained weight loss
- Numbness or tingling (nerve involvement)
- Kidney dysfunction
- Increased thirst or confusion (high calcium)
Some patients have no symptoms and are diagnosed through routine testing.
Diagnostic Evaluation for Multiple Myeloma
Comprehensive evaluation may include:
- Complete blood count (CBC)
- Kidney function tests and calcium levels
- Serum protein electrophoresis (SPEP) and immunofixation
- Free light chain assay
- Urine protein testing (UPEP)
- Bone marrow aspiration and biopsy
- Cytogenetic and molecular risk profiling
- Imaging to assess bone disease:
- Low-dose whole-body CT, MRI, or PET-CT (selected cases)
These tests confirm diagnosis, assess risk, and guide treatment.
Treatment Options for Multiple Myeloma
Treatment depends on disease stage, risk profile, symptoms, and patient fitness.
Systemic Drug Therapy
Common treatment strategies may include:
- Proteasome inhibitors
- Immunomodulatory drugs
- Steroids
- Monoclonal antibodies (immunotherapy)
Therapy is tailored to achieve disease control and reduce complications.
Stem Cell Transplant (Selected Cases)
- Autologous stem cell transplant may be recommended for eligible patients
- Often performed after initial treatment response
- Requires specialized center coordination
Supportive Care
Supportive therapy is essential and may include:
- Bone-strengthening medications
- Pain management
- Infection prevention
- Treatment of anemia
- Kidney protection strategies
Myeloma treatment is long-term and requires structured monitoring.
Treatment Journey in Türkiye
- Pre-Arrival Case Review
Medical history, labs, and imaging are reviewed in advance. - Specialist Consultation
A myeloma specialist evaluates the case and confirms diagnostic needs. - Diagnostic Confirmation and Staging
Bone marrow testing and imaging are coordinated. - Personalized Treatment Planning
A structured treatment plan is developed with supportive care. - Treatment and Monitoring
Therapy is initiated with close monitoring of response and safety. - Follow-Up & International Coordination
Long-term follow-up planning and international continuity are arranged.
Expected Results & Benefits
- Accurate diagnosis and risk classification
- Personalized treatment based on international standards
- Improved symptom control and quality of life
- Reduced risk of fractures and kidney complications
- Clear monitoring plan for long-term disease management
Many patients achieve strong disease control with modern therapies.
Risks & Considerations
Multiple myeloma treatment may involve:
- Increased infection risk
- Fatigue and blood count suppression
- Nerve-related side effects with some therapies
- Need for long-term monitoring and follow-up
- Bone and kidney complications requiring supportive care
All treatment options are explained transparently before initiation.
What’s Included in Your Medical Trip
- Hematology-oncology consultation
- Review of prior medical reports and pathology
- Advanced diagnostic testing coordination
- Bone marrow biopsy coordination (if needed)
- Imaging evaluation for bone involvement
- Personalized treatment planning
- Supportive care coordination
- Interpreter services
- 24/7 patient support
- Medical reporting and international follow-up coordination
Averia Health ensures ethical, structured, and patient-centered myeloma care.
Frequently Asked Questions
Is multiple myeloma curable?
Myeloma is usually considered treatable but not always curable. Many patients achieve long-term disease control with modern therapy.
Is stem cell transplant necessary?
Not for all patients. It is recommended for selected eligible patients based on age, health, and disease profile.
How is myeloma monitored over time?
Through blood tests, urine tests, and imaging when needed.
Does myeloma always cause bone pain?
No. Some patients have no symptoms early and are diagnosed through lab abnormalities.
Can international patients continue care after returning home?
Yes. We provide medical summaries and follow-up coordination for continuity.
Ready to Start Your Health Journey?
Get advanced diagnosis and expert multiple myeloma treatment in Türkiye with trusted hematology-oncology care and full international coordination.
Request a free quote or contact us on WhatsApp to speak with our international care coordination team.
